Related Experiment Video

Updated: Jun 18, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Metastasis: wherefore arf thou?

Richard T Premont1, Robert Schmalzigaug

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Richard.Premont@Duke.edu

Current Biology : CB
|December 2, 2009
PubMed

Insights

The small GTP-binding protein, ADP-ribosylation factor 6 (Arf6), regulates cell motility in metastasis. This study reveals Arf6 also controls the release of microvesicles from the cell membrane, impacting cancer spread.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The small GTP-binding protein Arf6 is a known regulator of the actin cytoskeleton.
  • Arf6 plays a critical role in cell motility, a process crucial for cancer metastasis.

Purpose of the Study:

  • To investigate the role of Arf6 in the release of plasma-membrane-derived microvesicles.
  • To further elucidate the mechanisms by which Arf6 contributes to cancer metastasis.

Main Methods:

  • The study likely involved cell-based assays to observe Arf6 function.
  • Techniques to measure microvesicle release and analyze their content may have been employed.

Main Results:

  • A recent study identified Arf6 as a regulator of plasma-membrane-derived microvesicle release.
  • This adds a new function for Arf6 in the context of cancer metastasis.

Conclusions:

  • Arf6 has a multifaceted role in cancer metastasis, extending beyond cytoskeletal regulation.
  • The regulation of microvesicle release by Arf6 represents a novel mechanism contributing to cancer progression.

More Related Videos

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...